Ab Index-Nr. 616-013-00-5

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
616-013-00-5butyraldehyde oxime203-792-8110-69-0Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
H311
H302
H319
GHS06
Dgr
H311
H302
H319
   
616-014-00-02-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime
202-496-696-29-7Carc. 2
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H351
H312
H318
H317
GHS08
GHS05
GHS07
Dgr
H351
H312
H318
H317
   
616-015-00-6alachlor (ISO);
2-chloro-2',6'-diethyl-N-
(methoxymethyl)
acetanilide
240-110-815972-60-8Carc. 2
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H317
H410
 M = 10 
616-016-00-11-(3,4-dichlorophenylimino) thiosemicarbazide5836-73-7Acute Tox. 2 (1)H300GHS06
Dgr
H300   
616-017-00-7cartap hydrochloride239-309-215263-52-2Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
   
616-018-00-2N,N-diethyl-m-toluamide;
deet
205-149-7134-62-3Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H315
H412
GHS07
Wng
H302
H319
H315
H412
   
616-019-00-8perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenyl-
sulphonyl-o-tolyl)methane-
sulphonamide;
253-718-337924-13-3Acute Tox. 4
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
616-020-00-3tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-
2-yl)-1,3-dimethylurea
251-793-734014-18-1Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
616-021-00-9thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoro-
methyl-1,3,4-thiadiazol-2-
yl)urea
246-901-425366-23-8Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
616-022-00-4acetamide200-473-560-35-5Carc. 2H351GHS08
Wng
H351   
616-023-00-XN-hexadecyl(or octadecyl)-
N-hexadecyl(or octadecyl)benzamide
401-980-6Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
   
616-024-00-52-(4,4-dimethyl-2,5-dioxo-
oxazolidin-1-yl)-2-chloro-
5-(2-(2,4-di-tert-pentylphe-
noxy)butyramido)-4,4-di-
methyl-3-oxovaleranilide
402-260-454942-74-4Aquatic Chronic 4H413H413   
616-025-00-0valinamide402-840-720108-78-5Repr. 2
Eye Irrit. 2
Skin Sens. 1
H361f
(*)(*)(*)
H319
H317
GHS08
Wng
H361f
(*)(*)(*)
H319
H317
   
616-026-00-6thioacetamide200-541-462-55-5Carc. 1B
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H350
H302
H319
H315
H412
GHS08
GHS07
Dgr
H350
H302
H319
H315
H412
   
616-027-00-1tris(2-(2-hydroxyetho-
xy)ethyl)ammonium 3-
acetoacetamido-4-methoxy-
benzenesulfonate
403-760-5Skin Sens. 1H317GHS07
Wng
H317   
616-028-00-7N-(4-(3-(4-cyanophenyl)ur-
eido)-3-hydroxyphenyl)-2-
(2,4-di-tert-pentylphenoxy)oc-
tanamide
403-790-9108673-51-4Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-029-00-2N,N'-ethylenebis(vinylsulfo-
nylacetamide)
404-790-166710-66-5Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
616-030-00-8ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-
thiadiazol-2-yl)-
1,3-dimethylurea
250-010-630043-49-3Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
616-031-00-3dimethachlor (ISO);
2-chloro-N-(2,6-dimethyl-
phenyl)-N-(2-methoxy-
ethyl)acetamide;
256-625-650563-36-5Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
616-032-00-9diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-
(trifluoromethyl)phenoxy]-
3-pyridinecarboxamide
83164-33-4Aquatic Chronic 3H412H412   
616-033-00-4cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-
furyl)cyclopropanecarboxamide
274-050-969581-33-5Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
   
616-034-00-Xpyracarbolid; (ISO);
3,4-dihydro-6-methyl-2H-
pyran-5-carboxanilide
246-419-424691-76-7Aquatic Chronic 3H412H412   
616-035-00-5cymoxanil (ISO);
2-cyano-N-[(ethylamino)car-
bonyl]-2-(methoxyimino)ace-
tamide
261-043-057966-95-7Repr. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H373
(Blut, Thymus-
drüse)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361fd
H302
H373
(Blut, Thymus-
drüse)
H317
H410
 M = 1
M = 1
 
616-036-00-02-chloracetamide201-174-279-07-2Repr. 2
Acute Tox. 3 (*)
Skin Sens. 1
H361f
(*)(*)(*)
H301
H317
GHS06
GHS08
Dgr
H361f
(*)(*)(*)
H301
H317
 Skin Sens. 1;
H317: C ≥ 0,1 %
 
bis 28.02.2018
616-037-00-6
acetochlor (ISO);
2-chloro-N-(ethoxymethyl)-N-
(2-ethyl-6-methylphenyl)ace-
tamide
251-899-334256-82-1Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H335
H315
H317
H410
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-037-00-6
Acetochlor (ISO);
2-Chlor-N-(ethoxyme-
thyl)-N-(2-ethyl-6-me-
thylphenyl)acetamid
251-899-334256-82-1Carc. 2
Repr. 2
Acute Tox. 4
STOT SE 3
STOT RE 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361f
H332
H335
H373 (Nieren)
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361f
H332
H335
H373 (Nieren)
H315
H317
H410
 M = 1000
M = 100
 
616-038-00-1(4-aminophenyl)-N-methyl-
methylensulfona-
mide hydrochloride
406-010-588918-84-7Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
   
616-039-00-73',5'-dichloro-4'-ethyl-2'-
hydroxypalmitanilide
406-200-8117827-06-2Skin Sens. 1H317GHS07
Wng
H317   
616-040-00-2potassium N-(4-toluene-
sulfonyl)-4-toluene-
sulfonamide
406-650-597888-41-0Eye Dam. 1H318GHS05
Dgr
H318   
616-041-00-83',5'-dichloro-2-(2,4-di-
tert-pentylphenoxy)-
4'-ethyl-2'-hydroxyhexananilide
406-840-8101664-25-9Aquatic Chronic 4H413H413   
616-042-00-3N-(2-(6-ethyl-7-(4-methyl-
phenoxy)-1H-pyrazolo[1,5-
b][1,2,4]triazol-2-yl)propyl)-2-
octadecyloxybenzamide
407-070-5142859-67-4Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-043-00-9isoxaben (ISO);
N-[3-(1-ethyl-1-methylpro-
pyl)-1,2-oxazol-5-yl]-2,6-
dimethoxybenzamide
407-190-882558-50-7Aquatic Chronic 4H413H413   
616-044-00-4N-(3,5-dichloro-4-ethyl-2-
hydroxyphenyl)-
2-(3-pentadecylphenoxy)-
butanamide
402-510-2Aquatic Chronic 2H411GHS09H411   
616-045-00-X2'-(4-chloro-3-cyano-5-formyl-
2-thieny-lazo)-5'-diethylamino-
2-methoxyacetanilide
405-190-2122371-93-1Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-046-00-5N-(2-(6-chloro-7-methylpyrazo-
lo(1,5-b)-1,2,4-triazol-4-yl)pro-
pyl)-2-(2,4-di-tert-pentyl-
phenoxy)octanamide
406-390-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-047-00-0reaction mass of: 2,2',2'',2'''-(ethylenedinitrilo-
tetrakis-N,N-di(C16)al-
kylacetamide;
2,2',2'',2'''-(ethylenedinitrilo-
tetrakis-N,N-di(C18)alkylacetamide
406-640-0Skin Sens. 1H317GHS07
Wng
H317   
616-048-00-63'-trifluoromethylisobutyranilide406-740-41939-27-1STOT RE 2 (*)
Aquatic Chronic 2
H373 (*)(*)
H411
GHS08
GHS09
Wng
H373 (*)(*)
H411
   
616-049-00-12-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-
(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-
hexanamide
408-150-299141-89-6Aquatic Chronic 4H413H413   
616-050-00-7lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-
hexafluoro-propoxy)-
phenyl-aminocarbonyl]-2,6-
difluorobenzamide
410-690-9103055-07-8Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
616-051-00-2reaction mass of: 2,4 -bis(N'-(4-
methylphenyl)-ureido)-
toluene;
2,6 -bis(N'-(4-methylphenyl)-
ureido)-toluene
411-070-0Aquatic Chronic 4H413H413   
616-052-00-8formamide200-842-075-12-7Repr. 1BH360D
(*)(*)(*)
GHS08
Dgr
H360D
(*)(*)(*)
   
616-053-00-3N-methylacetamide201-182-679-16-3Repr. 1BH360D
(*)(*)(*)
GHS08
Dgr
H360D
(*)(*)(*)
   
616-054-00-9iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-
dioxo-N-isopropylimidazo-
lidine-1-carboxamide
253-178-936734-19-7Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
616-055-00-4propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethyl-
prop-2-ynyl)benzamide
245-951-423950-58-5Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
616-056-00-XN-methylformamide204-624-6123-39-7Repr. 1B
Acute Tox. 4 (*)
H360D
(*)(*)(*)
H312
GHS08
GHS07
Dg
H360D
(*)(*)(*)
H312
   
616-057-00-5reaction mass of: N-[3-hydroxy-
2-(2-methylacryloylamino-
methoxy)propoxymethyl]-
2-methylacrylamide;
N-[2,3-bis-(2-methylacry-
loylaminomethoxy)propoxy-
methyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacry-
loylaminomethoxymethyl)-
acrylamide;
N-(2,3-dihydroxypropoxy-
methyl)-2-methylacrylamide
412-790-8Carc. 1B
Muta. 2
STOT RE 2 (*)
H350
H341
H373 (*)(*)
GHS08
Dgr
H350
H341
H373 (*)(*)
   
616-058-00-01,3-bis(3-methyl-2,5-dioxo-
1H-pyrrolinylmethyl)benzene
412-570-1119462-56-5STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 (*)(*)
H318
H317
H410
   
616-059-00-64-((4-(diethylamino)-2
-ethoxyphenyl)imino)-1,4-
dihydro-1-oxo-N-propyl-2-
naphthalenecarboxamide
412-650-6121487-83-0Aquatic Chronic 4H413H413   
616-060-00-1Condensation product of:
3-(7-carboxyhept-1-yl)-6-
hexyl-4-cyclohexene-1,2-
dicarboxylic acid with polyamines (primarily amino-
ethyl-piperazine and triethylenetetramine)
413-770-1Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
   
616-061-00-7N,N'-1,6-hexanediylbis(N-
(2,2,6,6-tetramethyl-piperidin-
4-yl)-formamide
413-610-0124172-53-8Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
   
616-062-00-2N-[3-[(2-acetyloxy)ethyl](phe-
nyl-methyl)amino]-4-methoxy-
phenylacetamide
411-590-870693-57-1Skin Corr. 1B
Aquatic Chronic 3
Acute Tox. 3 (*)
H314
H412
GHS05
Dgr
H314
H412
   
616-063-00-83-dodecyl-(1-(1,2,2,6,6-penta-
methyl-4-piperidin)-yl)-2,5-
pyrrolidindione
411-920-0106917-30-0Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H373 (*)(*)
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H373 (*)(*)
H314
H410
   
616-064-00-3N–tert-butyl-3-methyl-
picolinamide
406-720-532998-95-1Aquatic Chronic 3H412H412   
616-065-00-93'-(3-acetyl-4-hydroxy-
phenyl)-1,1-diethylurea
411-970-379881-89-3Acute Tox. 4 (*)
STOT RE 2 (*)
H302
H373 (*)(*)
GHS08
GHS07
Wng
H302
H373 (*)(*)
   
616-066-00-45,6,12,13-tetrachloro-
anthra(2,1,9-def:6,5,10-
d'e'f')diisoquinoline-1,3,8,10
(2H,9H)-tetrone
405-100-1115662-06-1Repr. 2H361f
(*)(*)(*)
GHS08
Wng
H361f
(*)(*)(*)
   
616-067-00-Xdodecyl 3-(2-(3-benzyl-
4-ethoxy-2,5-dioxoi-
midazolidin-1-yl)-4,4-
dimethyl-3-oxovaleramido)-
4-chlorobenzoate
407-300-492683-20-0Aquatic Chronic 4H413H413   
616-068-00-5potassium 4-(11-methacrylami-
doundecanamido)benzene-
sulfonate
406-500-9174393-75-0Skin Sens. 1H317GHS07
Wng
H317   
616-069-00-01-hydroxy-5-(2-methylpro-
pyloxycarbonylamino)-
N-(3-dodecyloxypropyl)-2-
naphthoamide
406-210-2110560-22-0Aquatic Chronic 4H413H413   
616-070-00-6reaction mass of: 3,3'-dicyclo-
hexyl-1,1'-methylenebis(4,1-
phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-
octadecylureido)
benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methyle-
nebis(4,1-phenylene)diurea
406-530-2Aquatic Chronic 4H413H413   
616-071-00-1reaction mass of: bis(N-cyclo-
hexyl-N'-phenyleneurei-
do)methylene;
bis(N-octadecyl-N'-phenyle-
neureido)methylene;
bis(N-dicyclohexyl-N'-
phenyleneureido)methylene (1:2:1)
406-550-1Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-072-00-71-(2-deoxy-5-O-trityl-β-
D-threopentofura-
nosyl)thymine
407-120-655612-11-8Aquatic Chronic 4H413H413   
616-073-00-24'-ethoxy-2-benzimidazole-
anilide
407-600-5120187-29-3Muta. 2
Aquatic Chronic 4
H341
H413
GHS08
Wng
H341
H413
   
616-074-00-8N-butyl-2-(4-morpholinyl-
carbonyl)benzamide
407-730-2104958-67-0Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
   
616-075-00-3D,L-(N,N-diethyl-2-hydroxy-
2-phenylacetamide)
408-120-965197-96-8Acute Tox. 4 (*)
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
616-076-00-9tebufenozide (ISO);
N–tert-butyl-N'-(4-
ethylbenzoyl)-3,5-dime-
thylbenzohydrazide
412-850-3112410-23-8Aquatic Chronic 2H411GHS09H411   
616-077-00-4reaction mass of:
2-(9-methyl-1,3,8,10-tetraoxo-
2,3,9,10-tetrahydro-(1H,8H)-
anthra[2,1,9-def:
6,5,10-d'e'f']diisoquinolin-2-
ylethansulfonic acid;
potassium 2-(9-methyl-
1,3,8,10-tetraoxo-2,3,9,10-
tetrahydro-(1H,8H)-an-
thra[2,1,9-def: 6,5,10-d'e'f']diisoquino-
lin-2-ylethansulfate
411-310-4Eye Dam. 1H318GHS05
Dgr
H318   
616-078-00-X2-[2,4-bis(1,1-dimethyl-
ethyl)phenoxy]-N-(2-hydroxy-
5-methyl-phenyl)hexanamide
411-330-3104541-33-5Aquatic Chronic 4H413H413   
616-079-00-51,6-hexanediyl-bis(2-(2-(1-
ethylpentyl)-3-oxazolidi-
nyl)ethyl)carbamate
411-700-4140921-24-0Skin Sens. 1H317GHS07
Wng
H317   
616-080-00-04-(2-((3-ethyl-4-methyl-2-oxo-
pyrrolin-1-yl)carboxami-
do)ethyl)benzenesulfonamide)
411-850-0119018-29-0Aquatic Chronic 3H412H412   
616-081-00-65-bromo-8-naphtholactam413-480-524856-00-6Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
616-082-00-1N-(5-chloro-3-((4-(diethyl-
amino)-2-methyl-phenyl)imi-
no-4-methyl-6-oxo-1,4-cyclohe-
xadien-1-yl)benzamide
413-200-1129604-78-0Skin Sens. 1H317GHS07
Wng
H317   
616-083-00-7[2-[(4-nitrophenyl)ami-
no]ethyl]urea
410-700-127080-42-8Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
616-084-00-22,4-bis[N'-(4-methylphe-
nyl)ureido]toluene
411-790-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-085-00-83-(2,4-dichlorophenyl)-6-
fluoro-quinazoline-
2,4(1H,3H)-dione
412-190-6168900-02-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-086-00-32-acetylamino-6-chloro-
4-[(4-diethylamino)
2-methylphenyl-imino]-5-
methyl-1-oxo-
2,5-cyclohexadiene
412-250-1102387-48-4Aquatic Chronic 4H413H413   
616-087-00-9reaction mass of: 7,9,9-trimethyl-3,14-
dioxa-4,13-dioxo-5,12-
diazahexadecane-
1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-
4,13-dioxo-5,12-diazahexa-
decan-1,16-diyl-prop-2-enoate
412-260-652658-19-2Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411
   
616-088-00-42-aminosulfonyl-N,N-
dimethylnicotinamide
413-440-7112006-75-4Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
616-089-00-X5-(2,4-dioxo-1,2,3,4-tetra-
hydropyrimidine)-3-fluoro-
2-hydroxymethyltetrahydro-
furan
415-360-841107-56-6Muta. 2H341GHS08
Wng
H341   
616-090-00-51-(1,4-benzodioxan-2-yl-
carbonyl)piperazine
hydrochloride
415-660-970918-74-0Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H411
   
616-091-00-01,3,5-tris-[(2S and 2R)-2,3-
epoxypropyl]-1,3,5-triazine-
2,4,6-(1H,3H,5H)-trione
423-400-059653-74-6Muta. 1B
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
H340
H331
H302
H373 (*)(*)
H318
H317
GHS06
GHS08
GHS05
Dgr
H340
H331
H302
H373 (*)(*)
H318
H317
   
616-092-00-6Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene,
1-propene with N,N-di-2-propenylformamide
404-035-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
616-093-00-1Reaction products of:
anilineterephthalaldehyde-
o-toluidine condensate with maleic anhydride
406-620-1129217-90-9Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
bis 30.11.2018:
616-094-00-7
3,3'-dicyclohexyl-1,1'-
methylenebis(4,1-phenyle-
ne)diurea
406-370-358890-25-8Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
616-094-00-7
3,3-Dicyclohexyl-1',1'-
methylenbis-(4,1-pheny-
len)diharnstoff
406-370-358890-25-8Aquatic Chronic 4H413 H413   
616-095-00-23,3'-dioctadecyl-1,1'-methyle-
nebis(4,1-phenylene)diurea
406-690-343136-14-7Aquatic Chronic 4H413H413   
616-096-00-8N-(3-hexadecyloxy-2-
hydroxyprop-1-yl)-N-
(2-hydroxyethyl)palmitamide
408-110-4110483-07-3Aquatic Chronic 4H413H413   
616-097-00-3N,N'-1,4-phenylenebis(2-((2-
methoxy-4-nitrophenyl)azo)-
3-oxobutanamide
411-840-683372-55-8Aquatic Chronic 4H413H413   
616-098-00-91-[4-chloro-3-((2,2,3,3,3-penta-
fluoropropoxy)methyl)phenyl]-
5-phenyl-1H-1,2,4-
triazole-3-carboxamide
411-750-7119126-15-7Aquatic Chronic 2H411GHS09H411   
616-099-00-42-[4-[(4-hydroxyphenyl)sul-
fonyl]phenoxy]-4,4-di-
methyl-N-[5-[(methylsulfo-
nyl)amino]-2-[4-(1,1,3,3-
tetramethylbutyl)phenoxy]
phenyl]-3-oxopentanamide
414-170-2135937-20-1Aquatic Chronic 4H413H413   
616-100-00-81,3-dimethyl-1,3-bis(tri-
methylsilyl)urea
414-180-710218-17-4Acute Tox. 4 (*)
Skin Irrit. 2
H302
H315
GHS07
Wng
H302
H315
   
616-101-00-3(S)-N–tert-butyl-1,2,3,4-
tetrahydro-3-iso-
quinolinecarboxamide
414-600-9149182-72-9Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
616-102-00-9reaction mass of:
α-[3-(3-mercaptopropa-
noxycarbonylamino)methyl-
phenylaminocarbonyl]-ω-
[3-(3-mercaptopropanoxy-
carbonylamino)methyl-
phenylaminocarbonyloxy]-
poly-(oxyethylene-co-oxy-
propylene);
1,2-(or 1,3-)bis[α-(3-
mercaptopropanoxy-
carbonylamino)methyl-
phenylaminocarbonyl)-ω-
oxy-poly(oxyethylene-co-
oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercap-
topropanoxycarbonyl-
amino)methylphenylamino-
carbonyl)-ω-oxy-
poly-(oxyethylene-co-oxy-
propylene)]propane]
415-870-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
616-103-00-4(S,S)-trans-4-(acetylamino)-
5,6-dihydro-6-methyl-7,7-
dioxo-4H-thieno[2,3-b]thiopy-
ran-2-sulfonamide
415-030-3120298-38-6Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
616-104-00-Xbenalaxyl (ISO);
methyl N-(2,6-dimethyl-
phenyl)-N-(phenyla-
cetyl)-DL-alaninate
275-728-771626-11-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-105-00-5chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-
dimethylurea
239-592-215545-48-9Carc. 2
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d
(*)(*)(*)
H400
H410
GHS08
GHS09
Wng
H351
H361d
(*)(*)(*)
H410
   
616-106-00-0phenmedipham (ISO);
methyl 3-(3-methylcarba-
niloyloxy)carbanilate
237-199-013684-63-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-107-00-6cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-
(cyclohex-1-ene-1,2-
dicarboximido)phenyl]acrylate
142891-20-1Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
   
616-108-00-1iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxy-
carbonyl)phenyl]sul-
fonyl}carbamoyl)(4-methoxy-
6-methyl-1,3,5-triazin-2-
yl)azanide
144550-36-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-109-00-7sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-
2-yl)-3-(2-ethylsulfonylimi-
dazo[1,2-a]pyridin-3-yl)sulfony-
lurea
141776-32-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
616-110-00-2cyclanilide (ISO);
1-(2,4-dichloroanilinocar-
bonyl)cyclopropa-
necarboxylic acid
419-150-7113136-77-9Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411